Company Information
Ask for more detail from the seller
Contact SupplierErlonat is a targeted therapy. Erlonat is classified as a epidermal growth factor receptor (egfr) inhibitor - protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing.